Navigation Links
MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
Date:11/14/2007

rating activities:

Depreciation and amortization 3,447,503 2,949,486

Stock-based compensation 1,971,687 2,861,585

Deferred rent and credit on

lease concession (48,393) (4,297)

Amortization of premium on

marketable securities (69,242) 222,332

Loss on disposal of fixed assets 23,185

Recognition of advance payment

for potential sale of Keflex (1,000,000)

Changes in:

Accounts receivable (1,028,251) (1,255,473)

Inventories 988,477 (1,110,616)

Prepaid expenses and other

current assets 483,170 220,484

Deposits other than on

property and equipment, and

other assets 249,667 -

Accounts payable 705,533 1,215,109

Accrued expenses and advances (1,975,496) 608,590

Deferred product and contract

revenue (189,000) 270,061

Net cash used in

operating activities (28,662,041) (23,219,613)

Cash flows from investing activities:

Purchase of marketable securities (5,867,519) (13,274,560)

Sale and maturities of marketable

securities 5,530,000 19,655,000

Purchases of property and

equipment (246,330) (50,653)

Deposits on property and

equipment (1,150,624) (250,000)

Proceeds from sale of fixed

assets
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... North Carolina (PRWEB) December 25, 2014 ... North Carolina Retirement Community, recently showed their generous ... girls of the Catawba County Parenting Network- Grandparents ... the 10 children gathered around the largest Christmas ... to open presents purchased by residents of the ...
(Date:12/24/2014)... 2014 Epigenetics finds applications in a ... oncology, drug discovery, developmental biology, and research for metabolic ... of the most widely used techniques for the discovery ... prevalence of cancer is rapidly growing worldwide. In 2012, ... cancer deaths, and 32.6 million people living with cancer ...
(Date:12/24/2014)... Dr. Vu Ho, a Dallas based facial plastic ... med-spa with the addition of new Silk Peel skin ... and services. , “Silk Peel is a procedure that ... “As a result it can address issues like acne ... or blemishes.” , Similar to microdermabrasion, Silk Peel ...
(Date:12/24/2014)... Mike Billings , PT, MS, CEEAA, President ... PT, MBA, GCS, Director of Professional Development to discuss ... of the Improving Medicare Post-Acute Care Transformation Act ... the Infinicast, the two leaders discuss how the IMPACT ... to standardize post-acute assessment data for quality, payment, and ...
(Date:12/24/2014)... new, injectable weight-loss drug has been approved by the ... Tuesday approved Saxenda (liraglutide) for adults who are obese ... least one weight-related health condition, such as high blood ... taking the drug, made by Novo Nordisk, should still ... noted. "Obesity is a public health concern and ...
Breaking Medicine News(10 mins):Health News:Retirement Community Residents Make Impact During Holiday Season 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 3Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:FDA Approves New Weight-Loss Drug 2Health News:FDA Approves New Weight-Loss Drug 3
... Americans on Healthy Living and Eating, ROSEMONT, ... is partnering with the U.S. Department of Agriculture ... habits and make healthier,lifestyle choices as part of ... and End Childhood Obesity.", The USDA,s Center ...
... no longer just for doctors as PointOne ... WAUWATOSA, Wis., June 10 PointOne Systems, ... tool, known as,RedBox Technology, will begin providing reports ... dramatic change from the industry,s focus,on hospitals, research ...
... takes a toll on pros, study says , , TUESDAY, June ... hampers the performances of continent-crossing pro baseball players but may ... , An analysis of 10 years of pro baseball scores ... they were severely jet-lagged. The effect, however, wears off after ...
... 2008 Pregnant women can safely undergo essential dental ... to 21 weeks gestation, says a study published in ... American Dental Association . , Although obstetricians generally consider ... evidence has been lacking. To address this issue, researchers ...
... 10 As government,authorities reel from a record breaking ... a new book brings to light the science --,and ... being,promoted by the food and nuclear industries., Written ... of Food is timely and fact-filled. The book details ...
... DALLAS, June 10 BeaconEquity.com announces the,availability of TraderNotes ... can view all of the daily trading notes for ... Lantis Laser Inc. (Pink Sheets: LLSR),Elbit Imaging Ltd. (Nasdaq: ... ),Ophthalmic Imaging Systems Inc. (OTC Bulletin Board: OISI), Alcon ...
Cached Medicine News:Health News:National Dairy Council Joins USDA in 'Partnering With MyPyramid' 2Health News:PointOne Launches New Business Direction, Healthcare Analytics Beyond Hospitals 2Health News:Baseball Teams Strike Out When Jet-Lagged 2Health News:Baseball Teams Strike Out When Jet-Lagged 3Health News:Essential dental treatment safe for pregnant women, says ADA journal study 2Health News:New Book Reveals Decades-Long Food Safety PR Scam 2Health News:BeaconEquity.com Issues TraderNotes on Medical Instruments and Supplies Stocks: LLSR, EMITF, BLTI, OISI, ACL, LMNX, MELA, PMII 2Health News:BeaconEquity.com Issues TraderNotes on Medical Instruments and Supplies Stocks: LLSR, EMITF, BLTI, OISI, ACL, LMNX, MELA, PMII 3
(Date:12/24/2014)... Tianyin Pharmaceutical Co., Inc. (NYSE MKT: ... biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics ... the Company achieved the Public Notice (Gong Shi) ... of TPI,s Qionglai Facility (QLF) from the China ... period is a significant procedure of GMP certification ...
(Date:12/22/2014)... 22, 2014 NxStage Medical, Inc. (NASDAQ: ... dialysis products, announced today that the U.S. Food ... One™ to perform hemodialysis overnight while the patient ... hemodialysis. NxStage,s® System One is the first and ... this indication. Home nocturnal hemodialysis ...
(Date:12/22/2014)... -- ConvaTec, a privately-held medical products and technologies company, today ... Executive Officer of the company, effective December 22, 2014. ... "The Board of Directors of ConvaTec thanks Mr. Berger ... three years," said Magnus Lundberg , the Chairman ... the company is well positioned for the future."  The ...
Breaking Medicine Technology:TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
... 25, 2011 Mylan Inc. (Nasdaq: MYL ) today ... Inc. which will resolve litigation related to Lipitor ® Tablets, ... as Atorvastatin Calcium Tablets. The terms of the agreement are confidential, ... Department of Justice and the Federal Trade Commission. Lipitor ...
... Jan. 25, 2011 Codexis, Inc. (Nasdaq: ... in Japan, with Dainippon Sumitomo Pharma Co., Ltd. (DSP), ... Under the agreement, Codexis will supply biocatalysis ... selected undisclosed therapeutic products in its development pipeline.  Codexis ...
Cached Medicine Technology:Mylan Announces Lipitor® Settlement Agreement 2Codexis Signs First Japanese Biocatalysis Collaboration With Dainippon Sumitomo Pharma 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: